A New York-based biotech firm announced it has raised an additional $200 million in financing to advance commercialization of ...

Researchers in Shanghai have reported in a study, recently published in Science Advances, that they've successfully decoded ...

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials ...

The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

The partners aim to develop AI-powered, real-time, personalized brain-computer interface therapies for neurological disorders ...

Remember how, last week, we talked about tech giant Microsoft (MSFT) and its plans to get AI involved in medicine? Well, ...

Spanish brain-computer interface (BCI) company INBRAIN Neuroelectronics has announced its collaboration with Microsoft to explore AI applications for real-time brain-computer interface therapeutics.

Microsoft security researchers have discovered a new backdoor malware that uses the OpenAI Assistants API as a covert command ...

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced a strategic collaboration with Microsoft to explore ...

Synchron Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego The round was led by Double Point Ventures, alongside ...

Last month, a study showed Science Corp.’s PRIMA BCI retinal implant restored some vision to people with severe age-related macular degeneration. Meanwhile, Elon Musk’s Neuralink earlier this year ...